AB324P
Donkey Anti-Sheep/Goat IgG Antibody, HRP conjugate
Chemicon®, from donkey
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.46
Recommended Products
biological source
donkey
conjugate
peroxidase conjugate
antibody form
affinity purified immunoglobulin
antibody product type
secondary antibodies
clone
polyclonal
species reactivity
sheep, goat
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
western blot: suitable
shipped in
wet ice
General description
Affinity purified donkey anti sheep / goat immunoglobulin, HRP conjugated. Cross reactivity to human, rabbit, and mouse proteins is less than 2% by ELISA.
Application
Donkey Anti-Sheep/Goat IgG Antibody, HRP conjugate detects level of Donkey Sheep/Goat IgG & has been published & validated for use in ELISA & WB.
ELISA: 1:1,000-1:20,000
Immunoblotting: 1:100-1:2,000
Optimal working dilutions must be determined by the end user.
Immunoblotting: 1:100-1:2,000
Optimal working dilutions must be determined by the end user.
Research Category
Secondary & Control Antibodies
Secondary & Control Antibodies
Research Sub Category
Whole Immunoglobulin Secondary Antibodies
Whole Immunoglobulin Secondary Antibodies
Quality
The antibody is isolated from antisera by affinity purification. Undesired immune reactivity has been removed by solid phase adsorption.
Linkage
Replaces: AP305P
Physical form
ImmunoAffinity Purified
The conjugate is supplied in phosphate buffered saline, pH 7.2, with 0.5% (w/v) bovine serum albumin and 10% (w/v) glycerol, 0.04% Thymol plus 0.4% anti microbial preservative
Storage and Stability
Maintain at 2-8°C in undiluted aliquots for up to 6 months.
Use of sodium azide as a preservative will substantially inhibit the enzyme activity of HRP.
Use of sodium azide as a preservative will substantially inhibit the enzyme activity of HRP.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
signalword
Warning
hcodes
Hazard Classifications
Aquatic Chronic 3 - Eye Irrit. 2 - Skin Irrit. 2
Storage Class
12 - Non Combustible Liquids
wgk_germany
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Miriam Burmeister et al.
Science advances, 9(29), eadg0686-eadg0686 (2023-07-19)
The gelatinases, matrix metalloproteinase 2 (MMP-2) and MMP-9, are key for leukocyte penetration of the brain parenchymal border in neuroinflammation and the functional integrity of this barrier; however, it is unclear which MMP substrates are involved. Using a tailored, sensitive
Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells.
Epis, MR; Giles, KM; Kalinowski, FC; Barker, A; Cohen, RJ; Leedman, PJ
The Journal of Biological Chemistry null
Rachael Bartlett et al.
Purinergic signalling (2022-04-29)
Mutant superoxide dismutase 1 (SOD1) can be constitutively released from motor neurons and transmitted to naïve motor neurons to promote the progression of amyotrophic lateral sclerosis (ALS). However, the biological impacts of this process and the precise mechanisms of SOD1
Manabu Koike et al.
FEBS open bio, 9(6), 1052-1062 (2019-05-23)
Resistance to radiotherapy and chemotherapy is a common problem in the treatment of cancer in humans and companion animals, including cats. There is thus an urgent need to develop new treatments. Molecularly targeted therapies hold the promise of high specificity
Robert D Little et al.
Scientific reports, 7(1), 6311-6311 (2017-07-26)
Inflammatory activity in rheumatoid arthritis may alter the regulation of muscle mass leading to a secondary sarcopenia, commonly termed rheumatoid cachexia (RC). We characterized alterations to muscle structure and various pro-inflammatory, catabolic and regenerative markers in an animal model of
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
